|
 |
|
Maxter |
| One of the youngest divisions within Lupin's India formulations business it focuses on the Critical Care segment as well as making inroads into the field of Wound Management. Some of Maxter's products like Tazar and Merotrol are market leaders in their categories. Maxter is the fastest growing player in the critical-care segment with special focus on high-end injectables as well as other life-saving medicines and products. The division recorded a growth rate of 11% in FY 2010.
Key Products : Maxter
|
Product |
Therapeutic segment |
Product Rank in the
relevant segment |
|
Merotrol |
Meropenem |
1 |
|
Tazar |
Piperacillin +
Tazobactam |
1 |
|
Ceff |
Cephalexin Oral
Solids
|
3 |
|
Cetil |
Cefuroxime Oral
Solids
|
5 |
|
Cefantral |
Cefotaxime
Injectibles |
9 |
|
New Product :
Lupitum
| |
